Page last updated: 2024-12-07

1-((4-fluorobenzoylamino)ethyl)-4-(7-methoxy-1-naphthyl)piperazine hydrochloride

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

You are referring to **1-((4-fluorobenzoylamino)ethyl)-4-(7-methoxy-1-naphthyl)piperazine hydrochloride**, which is a synthetic compound with the following chemical formula: C24H27FN4O3 · HCl.

**This compound is a derivative of the piperazine class of molecules and exhibits several interesting pharmacological properties.** It has been investigated for its potential therapeutic use in the following areas:

* **Antidepressant Activity:** Some studies suggest that this compound might have antidepressant effects due to its ability to interact with serotonin receptors, which are implicated in mood regulation. However, further research is needed to confirm this activity.
* **Anti-inflammatory Activity:** The compound has demonstrated anti-inflammatory properties in certain experimental models. This could be related to its ability to modulate signaling pathways involved in inflammation.
* **Antioxidant Activity:** Preliminary research suggests that this compound might possess antioxidant properties, which could be beneficial in protecting cells from damage caused by free radicals.

**Importance for Research:**

This compound is of interest for research because it displays a unique combination of potential pharmacological activities. Its structure, with the fluorobenzoyl group and the 7-methoxy-1-naphthyl moiety, might contribute to its specific interactions with biological targets.

**Further Research:**

While promising, the research on this compound is still in its early stages. More studies are needed to:

* **Confirm its precise mechanism of action.**
* **Determine its safety and efficacy in animal models.**
* **Evaluate its potential for human clinical trials.**

It's crucial to note that this compound is **not currently approved for any therapeutic use** and should not be used without proper medical supervision.

1-((4-fluorobenzoylamino)ethyl)-4-(7-methoxy-1-naphthyl)piperazine hydrochloride: a 5-HT(1A) receptor agonist; RN given for HCl salt [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

4-fluoro-N-{2-[4-(7-methoxynaphthalen-1-yl)piperazin-1-yl]ethyl}benzamide hydrochloride : A hydrochloride salt that is obtained by reaction of 4-fluoro-N-{2-[4-(7-methoxynaphthalen-1-yl)piperazin-1-yl]ethyl}benzamide with one equivalent of hydrogen chloride. Highly potent selective 5-HT1A receptor full agonist (pKi values are 9.0, 6.6, 7.5, 6.6 and < 6.0 for 5-HT1A, 5-HT1B, 5-HT1C, 5-HT2 and 5-HT3 receptors respectively). Possibly binds between the agonist binding site and the G protein interaction switch site, affecting the activation mechanism, and may display positive cooperativity. Anxiolytic following central administration in vivo. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID131905
CHEBI ID64099
SCHEMBL ID3187184
MeSH IDM0244955

Synonyms (33)

Synonym
benzamide, 4-fluoro-n-(2-(4-(7-methoxy-1-naphthalenyl)-1-piperazinyl)ethyl)-, hydrochloride
4-fluoro-n-(2-(4-(7-methoxy-1-naphthalenyl)-1-piperazinyl)ethyl)benzamide hydrochloride
098102ri3w ,
s 24506
unii-098102ri3w
4-fluoro-n-{2-[4-(7-methoxynaphthalen-1-yl)piperazin-1-yl]ethyl}benzamide hydrochloride
135721-98-1
s 14506 hydrochloride
1-((4-fluorobenzoylamino)ethyl)-4-(7-methoxy-1-naphthyl)piperazine hydrochloride
FT-0643238
4-fluoro-n-[2-[4-(7-methoxy-1-naphthalenyl)-1-piperazinyl]ethyl]benzamide hydrochloride
s14506 hydrochloride
s 14506 monohydrochloride
CHEBI:64099
s14506 monohydrochloride
AKOS022180966
SCHEMBL3187184
4-fluoro-n-[2-[4-(7-methoxy-1-naphthalenyl)-1-piperazinyl]ethyl]benzamidehydrochloride
DTXSID4042628
286369-38-8
s-14506 hydrochloride
benzamide,4-fluoro-n-[2-[4-(7-methoxy-1-naphthalenyl)-1-piperazinyl]ethyl]-,hydrochloride (1:?)
SR-01000597765-1
sr-01000597765
J-006763
4-fluoro-n-(2-(4-(7-methoxynaphthalen-1-yl)piperazin-1-yl)ethyl)benzamide hydrochloride
Q27133029
MS-28000
4-fluoro-n-[2-[4-(7-methoxynaphthalen-1-yl)piperazin-1-yl]ethyl]benzamide;hydrochloride
HY-110024
s-14506 (hydrochloride)
benzamide,4-fluoro-n-[2-[4-(7-methoxy-1-naphthalenyl)-1-piperazinyl]ethyl]-,hydrochloride(1:?)
s14506hydrochloride

Research Excerpts

Bioavailability

ExcerptReferenceRelevance
" Data were analysed by non-compartmental analysis, in order to evaluate the elimination constant, the half-life, the area under the curve and the bioavailability for each system."( The use of additives to modulate the release of a sparingly water soluble drug entrapped in PLA50 microparticles: in vivo investigation.
Coudane, J; Mallard, C; Rault, I; Vert, M,
)
0.13

Dosage Studied

ExcerptRelevanceReference
"63 mg/kg) shifted the dose-response curve of each agonist to the right in a dose-dependent manner."( Estimation of apparent pA2 values for WAY 100635 at 5-HT1A receptors regulating 5-hydroxytryptamine release in anaesthetised rats.
Assié, MB; Koek, W, 2000
)
0.31
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (2)

RoleDescription
serotonergic agonistAn agent that has an affinity for serotonin receptors and is able to mimic the effects of serotonin by stimulating the physiologic activity at the cell receptors. Serotonin agonists are used as antidepressants, anxiolytics, and in the treatment of migraine disorders.
anxiolytic drugAnxiolytic drugs are agents that alleviate anxiety, tension, and anxiety disorders, promote sedation, and have a calming effect without affecting clarity of consciousness or neurologic conditions.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (1)

ClassDescription
hydrochlorideA salt formally resulting from the reaction of hydrochloric acid with an organic base.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Research

Studies (5)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's3 (60.00)18.2507
2000's2 (40.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.00

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.00 (24.57)
Research Supply Index2.20 (2.92)
Research Growth Index4.20 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.00)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other8 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]